nodes	percent_of_prediction	percent_of_DWPC	metapath
Labetalol—ADRB2—ulcerative colitis	0.447	1	CbGaD
Labetalol—Salicylamide—Mesalazine—ulcerative colitis	0.213	0.516	CrCrCtD
Labetalol—Salsalate—Olsalazine—ulcerative colitis	0.2	0.484	CrCrCtD
Labetalol—Ketoprofen—CXCR1—ulcerative colitis	0.000987	0.179	CrCbGaD
Labetalol—ADRB3—Adrenoceptors—ADRB2—ulcerative colitis	0.000718	0.0863	CbGpPWpGaD
Labetalol—ADRB1—Adrenoceptors—ADRB2—ulcerative colitis	0.000426	0.0512	CbGpPWpGaD
Labetalol—Salmeterol—ADRB2—ulcerative colitis	0.000352	0.0639	CrCbGaD
Labetalol—Ritodrine—ADRB2—ulcerative colitis	0.000339	0.0615	CrCbGaD
Labetalol—Fenoterol—ADRB2—ulcerative colitis	0.000339	0.0615	CrCbGaD
Labetalol—Arbutamine—ADRB2—ulcerative colitis	0.000317	0.0575	CrCbGaD
Labetalol—Formoterol—ADRB2—ulcerative colitis	0.000307	0.0559	CrCbGaD
Labetalol—Arformoterol—ADRB2—ulcerative colitis	0.000307	0.0559	CrCbGaD
Labetalol—Dobutamine—ADRB2—ulcerative colitis	0.000291	0.053	CrCbGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.000278	0.0335	CbGpPWpGaD
Labetalol—Salsalate—PTGS1—ulcerative colitis	0.000261	0.0474	CrCbGaD
Labetalol—ADRB3—Monoamine GPCRs—ADRB2—ulcerative colitis	0.000254	0.0305	CbGpPWpGaD
Labetalol—Ketoprofen—CXCL8—ulcerative colitis	0.000249	0.0453	CrCbGaD
Labetalol—Fenoprofen—PTGS1—ulcerative colitis	0.000215	0.0391	CrCbGaD
Labetalol—ADRB3—Amine ligand-binding receptors—ADRB2—ulcerative colitis	0.000213	0.0257	CbGpPWpGaD
Labetalol—CYP2D6—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000209	0.0251	CbGpPWpGaD
Labetalol—Mirabegron—ALB—ulcerative colitis	0.000184	0.0334	CrCbGaD
Labetalol—Mirabegron—ABCB1—ulcerative colitis	0.000175	0.0318	CrCbGaD
Labetalol—Isoprenaline—ADRB2—ulcerative colitis	0.000165	0.03	CrCbGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.000165	0.0199	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR35—ulcerative colitis	0.000162	0.0194	CbGpPWpGaD
Labetalol—ADRB1—Monoamine GPCRs—ADRB2—ulcerative colitis	0.000151	0.0181	CbGpPWpGaD
Labetalol—Salsalate—PTGS2—ulcerative colitis	0.000149	0.0271	CrCbGaD
Labetalol—Flurbiprofen—PTGS1—ulcerative colitis	0.000141	0.0255	CrCbGaD
Labetalol—ADRB2—GPCRs, Other—CXCR1—ulcerative colitis	0.000133	0.016	CbGpPWpGaD
Labetalol—Visual impairment—Betamethasone—ulcerative colitis	0.000128	0.00102	CcSEcCtD
Labetalol—Visual impairment—Dexamethasone—ulcerative colitis	0.000128	0.00102	CcSEcCtD
Labetalol—Feeling abnormal—Mesalazine—ulcerative colitis	0.000128	0.00102	CcSEcCtD
Labetalol—Mental disorder—Methylprednisolone—ulcerative colitis	0.000128	0.00102	CcSEcCtD
Labetalol—Erythema—Triamcinolone—ulcerative colitis	0.000128	0.00101	CcSEcCtD
Labetalol—Erythema—Methylprednisolone—ulcerative colitis	0.000127	0.00101	CcSEcCtD
Labetalol—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000127	0.00101	CcSEcCtD
Labetalol—Ketoprofen—PTGS1—ulcerative colitis	0.000127	0.0231	CrCbGaD
Labetalol—Angioedema—Prednisolone—ulcerative colitis	0.000127	0.00101	CcSEcCtD
Labetalol—ADRB1—Amine ligand-binding receptors—ADRB2—ulcerative colitis	0.000127	0.0152	CbGpPWpGaD
Labetalol—Dizziness—Budesonide—ulcerative colitis	0.000126	0.00101	CcSEcCtD
Labetalol—Hypersensitivity—Azathioprine—ulcerative colitis	0.000126	0.001	CcSEcCtD
Labetalol—Ill-defined disorder—Hydrocortisone—ulcerative colitis	0.000126	0.000999	CcSEcCtD
Labetalol—Malaise—Prednisolone—ulcerative colitis	0.000125	0.000995	CcSEcCtD
Labetalol—Vertigo—Prednisolone—ulcerative colitis	0.000125	0.000991	CcSEcCtD
Labetalol—Syncope—Prednisolone—ulcerative colitis	0.000124	0.000989	CcSEcCtD
Labetalol—Angioedema—Hydrocortisone—ulcerative colitis	0.000124	0.000984	CcSEcCtD
Labetalol—Urticaria—Mesalazine—ulcerative colitis	0.000124	0.000982	CcSEcCtD
Labetalol—Fenoprofen—PTGS2—ulcerative colitis	0.000123	0.0224	CrCbGaD
Labetalol—Body temperature increased—Mesalazine—ulcerative colitis	0.000123	0.000977	CcSEcCtD
Labetalol—Abdominal pain—Mesalazine—ulcerative colitis	0.000123	0.000977	CcSEcCtD
Labetalol—Malaise—Hydrocortisone—ulcerative colitis	0.000122	0.000971	CcSEcCtD
Labetalol—Loss of consciousness—Prednisolone—ulcerative colitis	0.000122	0.000969	CcSEcCtD
Labetalol—Vertigo—Hydrocortisone—ulcerative colitis	0.000122	0.000968	CcSEcCtD
Labetalol—Vomiting—Budesonide—ulcerative colitis	0.000122	0.000966	CcSEcCtD
Labetalol—Syncope—Hydrocortisone—ulcerative colitis	0.000122	0.000966	CcSEcCtD
Labetalol—Rash—Budesonide—ulcerative colitis	0.000121	0.000958	CcSEcCtD
Labetalol—Dermatitis—Budesonide—ulcerative colitis	0.00012	0.000958	CcSEcCtD
Labetalol—Headache—Budesonide—ulcerative colitis	0.00012	0.000952	CcSEcCtD
Labetalol—Hypertension—Prednisolone—ulcerative colitis	0.00012	0.000952	CcSEcCtD
Labetalol—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000119	0.000947	CcSEcCtD
Labetalol—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.000118	0.000941	CcSEcCtD
Labetalol—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000118	0.000939	CcSEcCtD
Labetalol—Bradycardia—Prednisone—ulcerative colitis	0.000118	0.000937	CcSEcCtD
Labetalol—Alopecia—Dexamethasone—ulcerative colitis	0.000118	0.000934	CcSEcCtD
Labetalol—Alopecia—Betamethasone—ulcerative colitis	0.000118	0.000934	CcSEcCtD
Labetalol—Hypertension—Hydrocortisone—ulcerative colitis	0.000117	0.00093	CcSEcCtD
Labetalol—Diarrhoea—Azathioprine—ulcerative colitis	0.000117	0.000929	CcSEcCtD
Labetalol—Discomfort—Prednisolone—ulcerative colitis	0.000117	0.000928	CcSEcCtD
Labetalol—Angioedema—Triamcinolone—ulcerative colitis	0.000117	0.000927	CcSEcCtD
Labetalol—Angioedema—Methylprednisolone—ulcerative colitis	0.000116	0.000925	CcSEcCtD
Labetalol—ADRB3—G alpha (s) signalling events—PTGER4—ulcerative colitis	0.000116	0.014	CbGpPWpGaD
Labetalol—Erythema—Betamethasone—ulcerative colitis	0.000116	0.00092	CcSEcCtD
Labetalol—Erythema—Dexamethasone—ulcerative colitis	0.000116	0.00092	CcSEcCtD
Labetalol—Hallucination—Prednisone—ulcerative colitis	0.000115	0.000916	CcSEcCtD
Labetalol—Malaise—Triamcinolone—ulcerative colitis	0.000115	0.000915	CcSEcCtD
Labetalol—Malaise—Methylprednisolone—ulcerative colitis	0.000115	0.000913	CcSEcCtD
Labetalol—Vertigo—Triamcinolone—ulcerative colitis	0.000115	0.000911	CcSEcCtD
Labetalol—Hypersensitivity—Mesalazine—ulcerative colitis	0.000115	0.000911	CcSEcCtD
Labetalol—Syncope—Triamcinolone—ulcerative colitis	0.000114	0.000909	CcSEcCtD
Labetalol—Vertigo—Methylprednisolone—ulcerative colitis	0.000114	0.000909	CcSEcCtD
Labetalol—Syncope—Methylprednisolone—ulcerative colitis	0.000114	0.000907	CcSEcCtD
Labetalol—Discomfort—Hydrocortisone—ulcerative colitis	0.000114	0.000906	CcSEcCtD
Labetalol—Nausea—Budesonide—ulcerative colitis	0.000114	0.000903	CcSEcCtD
Labetalol—Oedema—Prednisolone—ulcerative colitis	0.000113	0.0009	CcSEcCtD
Labetalol—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000113	0.0009	CcSEcCtD
Labetalol—Dizziness—Azathioprine—ulcerative colitis	0.000113	0.000897	CcSEcCtD
Labetalol—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000112	0.000891	CcSEcCtD
Labetalol—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000112	0.000889	CcSEcCtD
Labetalol—Asthenia—Mesalazine—ulcerative colitis	0.000112	0.000887	CcSEcCtD
Labetalol—Shock—Prednisolone—ulcerative colitis	0.000111	0.000886	CcSEcCtD
Labetalol—Oedema—Hydrocortisone—ulcerative colitis	0.000111	0.000879	CcSEcCtD
Labetalol—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000111	0.000879	CcSEcCtD
Labetalol—Hypertension—Triamcinolone—ulcerative colitis	0.00011	0.000876	CcSEcCtD
Labetalol—Pruritus—Mesalazine—ulcerative colitis	0.00011	0.000875	CcSEcCtD
Labetalol—Hypertension—Methylprednisolone—ulcerative colitis	0.00011	0.000874	CcSEcCtD
Labetalol—Fenoprofen—ALB—ulcerative colitis	0.00011	0.0199	CrCbGaD
Labetalol—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000109	0.00087	CcSEcCtD
Labetalol—Shock—Hydrocortisone—ulcerative colitis	0.000109	0.000865	CcSEcCtD
Labetalol—Vomiting—Azathioprine—ulcerative colitis	0.000109	0.000863	CcSEcCtD
Labetalol—Rash—Azathioprine—ulcerative colitis	0.000108	0.000856	CcSEcCtD
Labetalol—Dermatitis—Azathioprine—ulcerative colitis	0.000108	0.000855	CcSEcCtD
Labetalol—Flushing—Prednisone—ulcerative colitis	0.000107	0.000854	CcSEcCtD
Labetalol—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000107	0.000854	CcSEcCtD
Labetalol—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000107	0.000854	CcSEcCtD
Labetalol—Discomfort—Triamcinolone—ulcerative colitis	0.000107	0.000853	CcSEcCtD
Labetalol—Discomfort—Methylprednisolone—ulcerative colitis	0.000107	0.000851	CcSEcCtD
Labetalol—Headache—Azathioprine—ulcerative colitis	0.000107	0.00085	CcSEcCtD
Labetalol—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000107	0.00085	CcSEcCtD
Labetalol—Diarrhoea—Mesalazine—ulcerative colitis	0.000106	0.000846	CcSEcCtD
Labetalol—Angioedema—Betamethasone—ulcerative colitis	0.000106	0.000841	CcSEcCtD
Labetalol—Angioedema—Dexamethasone—ulcerative colitis	0.000106	0.000841	CcSEcCtD
Labetalol—Confusional state—Methylprednisolone—ulcerative colitis	0.000105	0.000833	CcSEcCtD
Labetalol—Malaise—Betamethasone—ulcerative colitis	0.000104	0.00083	CcSEcCtD
Labetalol—Malaise—Dexamethasone—ulcerative colitis	0.000104	0.00083	CcSEcCtD
Labetalol—ADRB2—GPCRs, Other—CXCR2—ulcerative colitis	0.000104	0.0125	CbGpPWpGaD
Labetalol—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000104	0.000828	CcSEcCtD
Labetalol—Oedema—Triamcinolone—ulcerative colitis	0.000104	0.000828	CcSEcCtD
Labetalol—Vertigo—Dexamethasone—ulcerative colitis	0.000104	0.000827	CcSEcCtD
Labetalol—Vertigo—Betamethasone—ulcerative colitis	0.000104	0.000827	CcSEcCtD
Labetalol—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000104	0.000826	CcSEcCtD
Labetalol—Syncope—Betamethasone—ulcerative colitis	0.000104	0.000825	CcSEcCtD
Labetalol—Syncope—Dexamethasone—ulcerative colitis	0.000104	0.000825	CcSEcCtD
Labetalol—Hypotension—Hydrocortisone—ulcerative colitis	0.000103	0.000821	CcSEcCtD
Labetalol—Dizziness—Mesalazine—ulcerative colitis	0.000103	0.000817	CcSEcCtD
Labetalol—Shock—Triamcinolone—ulcerative colitis	0.000102	0.000814	CcSEcCtD
Labetalol—Alopecia—Prednisone—ulcerative colitis	0.000102	0.000813	CcSEcCtD
Labetalol—Shock—Methylprednisolone—ulcerative colitis	0.000102	0.000813	CcSEcCtD
Labetalol—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000102	0.000809	CcSEcCtD
Labetalol—Loss of consciousness—Betamethasone—ulcerative colitis	0.000102	0.000809	CcSEcCtD
Labetalol—Paraesthesia—Prednisolone—ulcerative colitis	0.000102	0.000808	CcSEcCtD
Labetalol—Mental disorder—Prednisone—ulcerative colitis	0.000101	0.000807	CcSEcCtD
Labetalol—Nausea—Azathioprine—ulcerative colitis	0.000101	0.000806	CcSEcCtD
Labetalol—Erythema—Prednisone—ulcerative colitis	0.000101	0.000801	CcSEcCtD
Labetalol—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000101	0.0008	CcSEcCtD
Labetalol—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.0001	0.000798	CcSEcCtD
Labetalol—Hypertension—Dexamethasone—ulcerative colitis	0.0001	0.000794	CcSEcCtD
Labetalol—Hypertension—Betamethasone—ulcerative colitis	0.0001	0.000794	CcSEcCtD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	9.98e-05	0.012	CbGpPWpGaD
Labetalol—Paraesthesia—Hydrocortisone—ulcerative colitis	9.93e-05	0.000789	CcSEcCtD
Labetalol—Vomiting—Mesalazine—ulcerative colitis	9.89e-05	0.000786	CcSEcCtD
Labetalol—Rash—Mesalazine—ulcerative colitis	9.81e-05	0.000779	CcSEcCtD
Labetalol—Dermatitis—Mesalazine—ulcerative colitis	9.8e-05	0.000779	CcSEcCtD
Labetalol—Headache—Mesalazine—ulcerative colitis	9.74e-05	0.000774	CcSEcCtD
Labetalol—Discomfort—Betamethasone—ulcerative colitis	9.74e-05	0.000774	CcSEcCtD
Labetalol—Discomfort—Dexamethasone—ulcerative colitis	9.74e-05	0.000774	CcSEcCtD
Labetalol—Dyspepsia—Hydrocortisone—ulcerative colitis	9.73e-05	0.000774	CcSEcCtD
Labetalol—Hypotension—Methylprednisolone—ulcerative colitis	9.71e-05	0.000772	CcSEcCtD
Labetalol—Pain—Prednisolone—ulcerative colitis	9.68e-05	0.00077	CcSEcCtD
Labetalol—Fatigue—Hydrocortisone—ulcerative colitis	9.53e-05	0.000758	CcSEcCtD
Labetalol—Vision blurred—Prednisone—ulcerative colitis	9.5e-05	0.000755	CcSEcCtD
Labetalol—Pain—Hydrocortisone—ulcerative colitis	9.46e-05	0.000752	CcSEcCtD
Labetalol—Oedema—Betamethasone—ulcerative colitis	9.45e-05	0.000751	CcSEcCtD
Labetalol—Oedema—Dexamethasone—ulcerative colitis	9.45e-05	0.000751	CcSEcCtD
Labetalol—Anaphylactic shock—Betamethasone—ulcerative colitis	9.45e-05	0.000751	CcSEcCtD
Labetalol—Anaphylactic shock—Dexamethasone—ulcerative colitis	9.45e-05	0.000751	CcSEcCtD
Labetalol—Ill-defined disorder—Prednisone—ulcerative colitis	9.35e-05	0.000744	CcSEcCtD
Labetalol—Paraesthesia—Triamcinolone—ulcerative colitis	9.35e-05	0.000743	CcSEcCtD
Labetalol—Feeling abnormal—Prednisolone—ulcerative colitis	9.33e-05	0.000742	CcSEcCtD
Labetalol—Paraesthesia—Methylprednisolone—ulcerative colitis	9.33e-05	0.000742	CcSEcCtD
Labetalol—Shock—Betamethasone—ulcerative colitis	9.3e-05	0.000739	CcSEcCtD
Labetalol—Shock—Dexamethasone—ulcerative colitis	9.3e-05	0.000739	CcSEcCtD
Labetalol—Dyspnoea—Triamcinolone—ulcerative colitis	9.28e-05	0.000738	CcSEcCtD
Labetalol—Nausea—Mesalazine—ulcerative colitis	9.24e-05	0.000734	CcSEcCtD
Labetalol—Angioedema—Prednisone—ulcerative colitis	9.21e-05	0.000732	CcSEcCtD
Labetalol—Dyspepsia—Triamcinolone—ulcerative colitis	9.17e-05	0.000729	CcSEcCtD
Labetalol—Dyspepsia—Methylprednisolone—ulcerative colitis	9.15e-05	0.000727	CcSEcCtD
Labetalol—Hyperhidrosis—Dexamethasone—ulcerative colitis	9.13e-05	0.000726	CcSEcCtD
Labetalol—Hyperhidrosis—Betamethasone—ulcerative colitis	9.13e-05	0.000726	CcSEcCtD
Labetalol—Feeling abnormal—Hydrocortisone—ulcerative colitis	9.11e-05	0.000724	CcSEcCtD
Labetalol—Malaise—Prednisone—ulcerative colitis	9.09e-05	0.000723	CcSEcCtD
Labetalol—Vertigo—Prednisone—ulcerative colitis	9.06e-05	0.00072	CcSEcCtD
Labetalol—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	9.04e-05	0.000719	CcSEcCtD
Labetalol—Syncope—Prednisone—ulcerative colitis	9.04e-05	0.000719	CcSEcCtD
Labetalol—Urticaria—Prednisolone—ulcerative colitis	9e-05	0.000715	CcSEcCtD
Labetalol—Fatigue—Triamcinolone—ulcerative colitis	8.98e-05	0.000714	CcSEcCtD
Labetalol—Fatigue—Methylprednisolone—ulcerative colitis	8.96e-05	0.000712	CcSEcCtD
Labetalol—Pain—Triamcinolone—ulcerative colitis	8.9e-05	0.000708	CcSEcCtD
Labetalol—ADRB3—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	8.89e-05	0.0107	CbGpPWpGaD
Labetalol—Loss of consciousness—Prednisone—ulcerative colitis	8.86e-05	0.000704	CcSEcCtD
Labetalol—Hypotension—Betamethasone—ulcerative colitis	8.83e-05	0.000702	CcSEcCtD
Labetalol—Hypotension—Dexamethasone—ulcerative colitis	8.83e-05	0.000702	CcSEcCtD
Labetalol—ADRB3—G alpha (s) signalling events—ADRB2—ulcerative colitis	8.8e-05	0.0106	CbGpPWpGaD
Labetalol—Urticaria—Hydrocortisone—ulcerative colitis	8.79e-05	0.000698	CcSEcCtD
Labetalol—Body temperature increased—Hydrocortisone—ulcerative colitis	8.74e-05	0.000695	CcSEcCtD
Labetalol—Abdominal pain—Hydrocortisone—ulcerative colitis	8.74e-05	0.000695	CcSEcCtD
Labetalol—Hypertension—Prednisone—ulcerative colitis	8.7e-05	0.000692	CcSEcCtD
Labetalol—Feeling abnormal—Triamcinolone—ulcerative colitis	8.58e-05	0.000682	CcSEcCtD
Labetalol—Feeling abnormal—Methylprednisolone—ulcerative colitis	8.56e-05	0.000681	CcSEcCtD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	8.55e-05	0.0103	CbGpPWpGaD
Labetalol—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	8.5e-05	0.000675	CcSEcCtD
Labetalol—Paraesthesia—Betamethasone—ulcerative colitis	8.48e-05	0.000674	CcSEcCtD
Labetalol—Paraesthesia—Dexamethasone—ulcerative colitis	8.48e-05	0.000674	CcSEcCtD
Labetalol—Discomfort—Prednisone—ulcerative colitis	8.48e-05	0.000674	CcSEcCtD
Labetalol—Hypersensitivity—Prednisolone—ulcerative colitis	8.34e-05	0.000663	CcSEcCtD
Labetalol—Dyspepsia—Dexamethasone—ulcerative colitis	8.32e-05	0.000661	CcSEcCtD
Labetalol—Dyspepsia—Betamethasone—ulcerative colitis	8.32e-05	0.000661	CcSEcCtD
Labetalol—Urticaria—Triamcinolone—ulcerative colitis	8.27e-05	0.000658	CcSEcCtD
Labetalol—Urticaria—Methylprednisolone—ulcerative colitis	8.25e-05	0.000656	CcSEcCtD
Labetalol—Body temperature increased—Triamcinolone—ulcerative colitis	8.23e-05	0.000654	CcSEcCtD
Labetalol—Anaphylactic shock—Prednisone—ulcerative colitis	8.23e-05	0.000654	CcSEcCtD
Labetalol—Oedema—Prednisone—ulcerative colitis	8.23e-05	0.000654	CcSEcCtD
Labetalol—Abdominal pain—Methylprednisolone—ulcerative colitis	8.21e-05	0.000653	CcSEcCtD
Labetalol—Hypersensitivity—Hydrocortisone—ulcerative colitis	8.15e-05	0.000648	CcSEcCtD
Labetalol—Fatigue—Betamethasone—ulcerative colitis	8.15e-05	0.000647	CcSEcCtD
Labetalol—Fatigue—Dexamethasone—ulcerative colitis	8.15e-05	0.000647	CcSEcCtD
Labetalol—Shock—Prednisone—ulcerative colitis	8.1e-05	0.000643	CcSEcCtD
Labetalol—Pain—Betamethasone—ulcerative colitis	8.08e-05	0.000642	CcSEcCtD
Labetalol—Pain—Dexamethasone—ulcerative colitis	8.08e-05	0.000642	CcSEcCtD
Labetalol—Flurbiprofen—PTGS2—ulcerative colitis	8.03e-05	0.0146	CrCbGaD
Labetalol—Hyperhidrosis—Prednisone—ulcerative colitis	7.95e-05	0.000632	CcSEcCtD
Labetalol—Asthenia—Hydrocortisone—ulcerative colitis	7.93e-05	0.000631	CcSEcCtD
Labetalol—Propafenone—ABCB1—ulcerative colitis	7.83e-05	0.0142	CrCbGaD
Labetalol—Pruritus—Hydrocortisone—ulcerative colitis	7.82e-05	0.000622	CcSEcCtD
Labetalol—CYP2D6—Nicotine—ulcerative colitis	7.82e-05	0.438	CbGbCtD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	7.81e-05	0.00939	CbGpPWpGaD
Labetalol—Feeling abnormal—Dexamethasone—ulcerative colitis	7.79e-05	0.000619	CcSEcCtD
Labetalol—Feeling abnormal—Betamethasone—ulcerative colitis	7.79e-05	0.000619	CcSEcCtD
Labetalol—Gastrointestinal pain—Betamethasone—ulcerative colitis	7.73e-05	0.000614	CcSEcCtD
Labetalol—Gastrointestinal pain—Dexamethasone—ulcerative colitis	7.73e-05	0.000614	CcSEcCtD
Labetalol—Hypersensitivity—Triamcinolone—ulcerative colitis	7.67e-05	0.00061	CcSEcCtD
Labetalol—Hypersensitivity—Methylprednisolone—ulcerative colitis	7.65e-05	0.000608	CcSEcCtD
Labetalol—ADRB3—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	7.6e-05	0.00914	CbGpPWpGaD
Labetalol—Diarrhoea—Hydrocortisone—ulcerative colitis	7.57e-05	0.000601	CcSEcCtD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	7.51e-05	0.00902	CbGpPWpGaD
Labetalol—Urticaria—Dexamethasone—ulcerative colitis	7.51e-05	0.000597	CcSEcCtD
Labetalol—Urticaria—Betamethasone—ulcerative colitis	7.51e-05	0.000597	CcSEcCtD
Labetalol—Dizziness—Prednisolone—ulcerative colitis	7.49e-05	0.000595	CcSEcCtD
Labetalol—ADRB3—G alpha (s) signalling events—ADCY5—ulcerative colitis	7.47e-05	0.00898	CbGpPWpGaD
Labetalol—Asthenia—Triamcinolone—ulcerative colitis	7.47e-05	0.000594	CcSEcCtD
Labetalol—Body temperature increased—Dexamethasone—ulcerative colitis	7.47e-05	0.000594	CcSEcCtD
Labetalol—Abdominal pain—Dexamethasone—ulcerative colitis	7.47e-05	0.000594	CcSEcCtD
Labetalol—Abdominal pain—Betamethasone—ulcerative colitis	7.47e-05	0.000594	CcSEcCtD
Labetalol—Body temperature increased—Betamethasone—ulcerative colitis	7.47e-05	0.000594	CcSEcCtD
Labetalol—Asthenia—Methylprednisolone—ulcerative colitis	7.45e-05	0.000593	CcSEcCtD
Labetalol—Paraesthesia—Prednisone—ulcerative colitis	7.39e-05	0.000587	CcSEcCtD
Labetalol—Pruritus—Triamcinolone—ulcerative colitis	7.37e-05	0.000586	CcSEcCtD
Labetalol—Pruritus—Methylprednisolone—ulcerative colitis	7.35e-05	0.000584	CcSEcCtD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	7.34e-05	0.00883	CbGpPWpGaD
Labetalol—Dizziness—Hydrocortisone—ulcerative colitis	7.31e-05	0.000581	CcSEcCtD
Labetalol—Ketoprofen—PTGS2—ulcerative colitis	7.27e-05	0.0132	CrCbGaD
Labetalol—Dyspepsia—Prednisone—ulcerative colitis	7.24e-05	0.000576	CcSEcCtD
Labetalol—ADRB1—Melatonin metabolism and effects—NFKB1—ulcerative colitis	7.22e-05	0.00868	CbGpPWpGaD
Labetalol—Flurbiprofen—ALB—ulcerative colitis	7.16e-05	0.013	CrCbGaD
Labetalol—Rash—Prednisolone—ulcerative colitis	7.14e-05	0.000568	CcSEcCtD
Labetalol—Dermatitis—Prednisolone—ulcerative colitis	7.13e-05	0.000567	CcSEcCtD
Labetalol—Diarrhoea—Methylprednisolone—ulcerative colitis	7.11e-05	0.000565	CcSEcCtD
Labetalol—Fatigue—Prednisone—ulcerative colitis	7.09e-05	0.000564	CcSEcCtD
Labetalol—Headache—Prednisolone—ulcerative colitis	7.09e-05	0.000564	CcSEcCtD
Labetalol—Constipation—Prednisone—ulcerative colitis	7.04e-05	0.000559	CcSEcCtD
Labetalol—Vomiting—Hydrocortisone—ulcerative colitis	7.03e-05	0.000559	CcSEcCtD
Labetalol—CYP2D6—Cholecalciferol—ulcerative colitis	7.01e-05	0.393	CbGbCtD
Labetalol—Rash—Hydrocortisone—ulcerative colitis	6.97e-05	0.000554	CcSEcCtD
Labetalol—Dermatitis—Hydrocortisone—ulcerative colitis	6.97e-05	0.000554	CcSEcCtD
Labetalol—Headache—Hydrocortisone—ulcerative colitis	6.93e-05	0.000551	CcSEcCtD
Labetalol—ADRB1—G alpha (s) signalling events—PTGER4—ulcerative colitis	6.9e-05	0.00829	CbGpPWpGaD
Labetalol—Dizziness—Triamcinolone—ulcerative colitis	6.89e-05	0.000547	CcSEcCtD
Labetalol—Dizziness—Methylprednisolone—ulcerative colitis	6.87e-05	0.000546	CcSEcCtD
Labetalol—Feeling abnormal—Prednisone—ulcerative colitis	6.78e-05	0.000539	CcSEcCtD
Labetalol—Asthenia—Betamethasone—ulcerative colitis	6.78e-05	0.000539	CcSEcCtD
Labetalol—Asthenia—Dexamethasone—ulcerative colitis	6.78e-05	0.000539	CcSEcCtD
Labetalol—ADRB2—G alpha (s) signalling events—PTGER4—ulcerative colitis	6.75e-05	0.00811	CbGpPWpGaD
Labetalol—Gastrointestinal pain—Prednisone—ulcerative colitis	6.73e-05	0.000535	CcSEcCtD
Labetalol—Nausea—Prednisolone—ulcerative colitis	6.73e-05	0.000535	CcSEcCtD
Labetalol—ADRB2—Arf6 trafficking events—CDH1—ulcerative colitis	6.71e-05	0.00806	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	6.69e-05	0.00804	CbGpPWpGaD
Labetalol—Pruritus—Dexamethasone—ulcerative colitis	6.68e-05	0.000531	CcSEcCtD
Labetalol—Pruritus—Betamethasone—ulcerative colitis	6.68e-05	0.000531	CcSEcCtD
Labetalol—Vomiting—Triamcinolone—ulcerative colitis	6.62e-05	0.000526	CcSEcCtD
Labetalol—Vomiting—Methylprednisolone—ulcerative colitis	6.61e-05	0.000525	CcSEcCtD
Labetalol—Nausea—Hydrocortisone—ulcerative colitis	6.57e-05	0.000522	CcSEcCtD
Labetalol—Rash—Triamcinolone—ulcerative colitis	6.57e-05	0.000522	CcSEcCtD
Labetalol—Dermatitis—Triamcinolone—ulcerative colitis	6.56e-05	0.000521	CcSEcCtD
Labetalol—Rash—Methylprednisolone—ulcerative colitis	6.55e-05	0.000521	CcSEcCtD
Labetalol—Dermatitis—Methylprednisolone—ulcerative colitis	6.55e-05	0.00052	CcSEcCtD
Labetalol—Urticaria—Prednisone—ulcerative colitis	6.54e-05	0.00052	CcSEcCtD
Labetalol—Headache—Triamcinolone—ulcerative colitis	6.52e-05	0.000519	CcSEcCtD
Labetalol—ADRB3—GPCR ligand binding—CXCR1—ulcerative colitis	6.51e-05	0.00783	CbGpPWpGaD
Labetalol—Headache—Methylprednisolone—ulcerative colitis	6.51e-05	0.000517	CcSEcCtD
Labetalol—Body temperature increased—Prednisone—ulcerative colitis	6.5e-05	0.000517	CcSEcCtD
Labetalol—Abdominal pain—Prednisone—ulcerative colitis	6.5e-05	0.000517	CcSEcCtD
Labetalol—Ketoprofen—ALB—ulcerative colitis	6.48e-05	0.0118	CrCbGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	6.46e-05	0.00777	CbGpPWpGaD
Labetalol—Diarrhoea—Betamethasone—ulcerative colitis	6.46e-05	0.000514	CcSEcCtD
Labetalol—Diarrhoea—Dexamethasone—ulcerative colitis	6.46e-05	0.000514	CcSEcCtD
Labetalol—ADRB3—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	6.45e-05	0.00776	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	6.29e-05	0.00756	CbGpPWpGaD
Labetalol—Dizziness—Dexamethasone—ulcerative colitis	6.25e-05	0.000497	CcSEcCtD
Labetalol—Dizziness—Betamethasone—ulcerative colitis	6.25e-05	0.000497	CcSEcCtD
Labetalol—Nausea—Triamcinolone—ulcerative colitis	6.19e-05	0.000492	CcSEcCtD
Labetalol—Nausea—Methylprednisolone—ulcerative colitis	6.17e-05	0.000491	CcSEcCtD
Labetalol—Hypersensitivity—Prednisone—ulcerative colitis	6.06e-05	0.000482	CcSEcCtD
Labetalol—Vomiting—Betamethasone—ulcerative colitis	6.01e-05	0.000478	CcSEcCtD
Labetalol—Vomiting—Dexamethasone—ulcerative colitis	6.01e-05	0.000478	CcSEcCtD
Labetalol—Rash—Dexamethasone—ulcerative colitis	5.96e-05	0.000474	CcSEcCtD
Labetalol—Rash—Betamethasone—ulcerative colitis	5.96e-05	0.000474	CcSEcCtD
Labetalol—Dermatitis—Betamethasone—ulcerative colitis	5.95e-05	0.000473	CcSEcCtD
Labetalol—Dermatitis—Dexamethasone—ulcerative colitis	5.95e-05	0.000473	CcSEcCtD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	5.92e-05	0.00712	CbGpPWpGaD
Labetalol—Headache—Betamethasone—ulcerative colitis	5.92e-05	0.00047	CcSEcCtD
Labetalol—Headache—Dexamethasone—ulcerative colitis	5.92e-05	0.00047	CcSEcCtD
Labetalol—Asthenia—Prednisone—ulcerative colitis	5.9e-05	0.000469	CcSEcCtD
Labetalol—Pruritus—Prednisone—ulcerative colitis	5.82e-05	0.000463	CcSEcCtD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR1—ulcerative colitis	5.79e-05	0.00697	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—CCL20—ulcerative colitis	5.72e-05	0.00687	CbGpPWpGaD
Labetalol—Diarrhoea—Prednisone—ulcerative colitis	5.63e-05	0.000448	CcSEcCtD
Labetalol—Nausea—Betamethasone—ulcerative colitis	5.61e-05	0.000446	CcSEcCtD
Labetalol—Nausea—Dexamethasone—ulcerative colitis	5.61e-05	0.000446	CcSEcCtD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	5.54e-05	0.00666	CbGpPWpGaD
Labetalol—Dizziness—Prednisone—ulcerative colitis	5.44e-05	0.000433	CcSEcCtD
Labetalol—ADRB1—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	5.28e-05	0.00635	CbGpPWpGaD
Labetalol—Vomiting—Prednisone—ulcerative colitis	5.23e-05	0.000416	CcSEcCtD
Labetalol—ADRB1—G alpha (s) signalling events—ADRB2—ulcerative colitis	5.23e-05	0.00628	CbGpPWpGaD
Labetalol—Rash—Prednisone—ulcerative colitis	5.19e-05	0.000412	CcSEcCtD
Labetalol—Dermatitis—Prednisone—ulcerative colitis	5.18e-05	0.000412	CcSEcCtD
Labetalol—ADRB2—Calcium Regulation in the Cardiac Cell—CALM3—ulcerative colitis	5.16e-05	0.00621	CbGpPWpGaD
Labetalol—Headache—Prednisone—ulcerative colitis	5.15e-05	0.00041	CcSEcCtD
Labetalol—ADRB3—GPCR ligand binding—CXCR2—ulcerative colitis	5.1e-05	0.00613	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	5.08e-05	0.0061	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	5.07e-05	0.0061	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR1—ulcerative colitis	4.96e-05	0.00597	CbGpPWpGaD
Labetalol—ADRB3—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	4.9e-05	0.00589	CbGpPWpGaD
Labetalol—Nausea—Prednisone—ulcerative colitis	4.89e-05	0.000388	CcSEcCtD
Labetalol—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	4.82e-05	0.00579	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—CCR6—ulcerative colitis	4.79e-05	0.00576	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	4.64e-05	0.00557	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR2—ulcerative colitis	4.53e-05	0.00545	CbGpPWpGaD
Labetalol—ADRB1—Calcium Regulation in the Cardiac Cell—ADRB2—ulcerative colitis	4.51e-05	0.00542	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	4.46e-05	0.00536	CbGpPWpGaD
Labetalol—ADRB1—G alpha (s) signalling events—ADCY5—ulcerative colitis	4.44e-05	0.00533	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL20—ulcerative colitis	4.36e-05	0.00524	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	4.36e-05	0.00524	CbGpPWpGaD
Labetalol—ADRB2—G alpha (s) signalling events—ADCY5—ulcerative colitis	4.34e-05	0.00522	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR6—ulcerative colitis	4.26e-05	0.00512	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—PTGER4—ulcerative colitis	4.22e-05	0.00507	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	4.2e-05	0.00505	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	3.97e-05	0.00477	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR2—ulcerative colitis	3.89e-05	0.00467	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CXCR1—ulcerative colitis	3.86e-05	0.00465	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—GHRL—ulcerative colitis	3.86e-05	0.00464	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	3.84e-05	0.00461	CbGpPWpGaD
Labetalol—ADRB1—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	3.83e-05	0.0046	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CXCR1—ulcerative colitis	3.78e-05	0.00454	CbGpPWpGaD
Labetalol—ADRB2—GPCRs, Class A Rhodopsin-like—PTGER4—ulcerative colitis	3.75e-05	0.00451	CbGpPWpGaD
Labetalol—ADRB2—Calcium Regulation in the Cardiac Cell—ADCY5—ulcerative colitis	3.75e-05	0.0045	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	3.73e-05	0.00449	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CXCR1—ulcerative colitis	3.68e-05	0.00442	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR6—ulcerative colitis	3.65e-05	0.00439	CbGpPWpGaD
Labetalol—CYP2D6—Melatonin metabolism and effects—NFKB1—ulcerative colitis	3.54e-05	0.00425	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CCL20—ulcerative colitis	3.39e-05	0.00408	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CXCR1—ulcerative colitis	3.34e-05	0.00402	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CCL20—ulcerative colitis	3.32e-05	0.00399	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	3.29e-05	0.00395	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CCL20—ulcerative colitis	3.23e-05	0.00388	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PTGER4—ulcerative colitis	3.22e-05	0.00387	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—ADRB2—ulcerative colitis	3.2e-05	0.00384	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—GNA12—ulcerative colitis	3.04e-05	0.00365	CbGpPWpGaD
Labetalol—CYP2D6—Dexamethasone—ulcerative colitis	3.03e-05	0.17	CbGbCtD
Labetalol—ADRB1—GPCR ligand binding—CXCR2—ulcerative colitis	3.02e-05	0.00364	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	3.01e-05	0.00362	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CXCR2—ulcerative colitis	2.96e-05	0.00356	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—GHRL—ulcerative colitis	2.94e-05	0.00354	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CCL20—ulcerative colitis	2.93e-05	0.00353	CbGpPWpGaD
Labetalol—ADRB1—GPCRs, Class A Rhodopsin-like—ADRB2—ulcerative colitis	2.91e-05	0.0035	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CXCR2—ulcerative colitis	2.88e-05	0.00346	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CCR6—ulcerative colitis	2.84e-05	0.00342	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CCR6—ulcerative colitis	2.78e-05	0.00334	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—GNA12—ulcerative colitis	2.76e-05	0.00332	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CCR6—ulcerative colitis	2.71e-05	0.00325	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CXCR2—ulcerative colitis	2.61e-05	0.00314	CbGpPWpGaD
Labetalol—CYP2D6—Biological oxidations—PTGS1—ulcerative colitis	2.56e-05	0.00308	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—PTGER4—ulcerative colitis	2.5e-05	0.00301	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—ADRB2—ulcerative colitis	2.49e-05	0.00299	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CCR6—ulcerative colitis	2.46e-05	0.00296	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—PTGER4—ulcerative colitis	2.45e-05	0.00294	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—SEL1L—ulcerative colitis	2.4e-05	0.00288	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—PTGER4—ulcerative colitis	2.38e-05	0.00287	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—GHRL—ulcerative colitis	2.29e-05	0.00276	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—GHRL—ulcerative colitis	2.24e-05	0.0027	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CXCR1—ulcerative colitis	2.18e-05	0.00263	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—GHRL—ulcerative colitis	2.18e-05	0.00262	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—PTGER4—ulcerative colitis	2.16e-05	0.0026	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CXCR1—ulcerative colitis	2.14e-05	0.00257	CbGpPWpGaD
Labetalol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	2.03e-05	0.00244	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CXCR1—ulcerative colitis	1.98e-05	0.00238	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—GHRL—ulcerative colitis	1.98e-05	0.00238	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CXCR1—ulcerative colitis	1.97e-05	0.00237	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CXCR1—ulcerative colitis	1.94e-05	0.00233	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CALM3—ulcerative colitis	1.92e-05	0.00231	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CCL20—ulcerative colitis	1.92e-05	0.00231	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—ADRB2—ulcerative colitis	1.9e-05	0.00228	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CCL20—ulcerative colitis	1.88e-05	0.00225	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—ADRB2—ulcerative colitis	1.81e-05	0.00217	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—GNA12—ulcerative colitis	1.8e-05	0.00217	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—GNA12—ulcerative colitis	1.76e-05	0.00212	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCL20—ulcerative colitis	1.74e-05	0.00209	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCL20—ulcerative colitis	1.73e-05	0.00208	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CXCR2—ulcerative colitis	1.71e-05	0.00205	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCL20—ulcerative colitis	1.7e-05	0.00205	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CXCR2—ulcerative colitis	1.67e-05	0.00201	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—ADRB2—ulcerative colitis	1.64e-05	0.00197	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—GNA12—ulcerative colitis	1.64e-05	0.00197	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GNA12—ulcerative colitis	1.63e-05	0.00196	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CCR6—ulcerative colitis	1.61e-05	0.00193	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—GNA12—ulcerative colitis	1.6e-05	0.00193	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CCR6—ulcerative colitis	1.57e-05	0.00189	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CXCR2—ulcerative colitis	1.55e-05	0.00187	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CXCR2—ulcerative colitis	1.54e-05	0.00186	CbGpPWpGaD
Labetalol—ADRB3—GPCR ligand binding—CXCL8—ulcerative colitis	1.54e-05	0.00186	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—ADCY5—ulcerative colitis	1.53e-05	0.00184	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CXCR2—ulcerative colitis	1.52e-05	0.00183	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CCR6—ulcerative colitis	1.46e-05	0.00175	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CCR6—ulcerative colitis	1.45e-05	0.00175	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CCR6—ulcerative colitis	1.43e-05	0.00172	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—SEL1L—ulcerative colitis	1.42e-05	0.00171	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—PTGER4—ulcerative colitis	1.41e-05	0.0017	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—ADCY5—ulcerative colitis	1.39e-05	0.00167	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—SEL1L—ulcerative colitis	1.39e-05	0.00167	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—PTGER4—ulcerative colitis	1.38e-05	0.00166	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MAML2—ulcerative colitis	1.38e-05	0.00166	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—GHRL—ulcerative colitis	1.3e-05	0.00156	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—PTGER4—ulcerative colitis	1.28e-05	0.00154	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—PTGER4—ulcerative colitis	1.28e-05	0.00154	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—GHRL—ulcerative colitis	1.27e-05	0.00152	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—PTGER4—ulcerative colitis	1.26e-05	0.00151	CbGpPWpGaD
Labetalol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.2e-05	0.00145	CbGpPWpGaD
Labetalol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—ulcerative colitis	1.18e-05	0.00141	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—GHRL—ulcerative colitis	1.18e-05	0.00141	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCR1—ulcerative colitis	1.17e-05	0.00141	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—GHRL—ulcerative colitis	1.17e-05	0.00141	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—GHRL—ulcerative colitis	1.15e-05	0.00138	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCR1—ulcerative colitis	1.15e-05	0.00138	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CALM3—ulcerative colitis	1.14e-05	0.00137	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CALM3—ulcerative colitis	1.13e-05	0.00136	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RIPK2—ulcerative colitis	1.12e-05	0.00134	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CALM3—ulcerative colitis	1.11e-05	0.00134	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—ADRB2—ulcerative colitis	1.07e-05	0.00129	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CHP1—ulcerative colitis	1.05e-05	0.00126	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCL20—ulcerative colitis	1.03e-05	0.00124	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCL20—ulcerative colitis	1.01e-05	0.00121	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—ADRB2—ulcerative colitis	9.74e-06	0.00117	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ADRB2—ulcerative colitis	9.69e-06	0.00116	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GNA12—ulcerative colitis	9.67e-06	0.00116	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—JAK2—ulcerative colitis	9.56e-06	0.00115	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GNA12—ulcerative colitis	9.46e-06	0.00114	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCR2—ulcerative colitis	9.17e-06	0.0011	CbGpPWpGaD
Labetalol—ADRB1—GPCR ligand binding—CXCL8—ulcerative colitis	9.16e-06	0.0011	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—ADCY5—ulcerative colitis	9.1e-06	0.00109	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—DLD—ulcerative colitis	9.06e-06	0.00109	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCR2—ulcerative colitis	8.97e-06	0.00108	CbGpPWpGaD
Labetalol—ADRB2—GPCR ligand binding—CXCL8—ulcerative colitis	8.96e-06	0.00108	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—ADCY5—ulcerative colitis	8.9e-06	0.00107	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—CXCL8—ulcerative colitis	8.72e-06	0.00105	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—JAK2—ulcerative colitis	8.68e-06	0.00104	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CCR6—ulcerative colitis	8.62e-06	0.00104	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CCR6—ulcerative colitis	8.43e-06	0.00101	CbGpPWpGaD
Labetalol—ADRB3—GPCR downstream signaling—IL2—ulcerative colitis	8.34e-06	0.001	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—ADCY5—ulcerative colitis	8.26e-06	0.000993	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—ADCY5—ulcerative colitis	8.23e-06	0.000989	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MAML2—ulcerative colitis	8.17e-06	0.000982	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—ADCY5—ulcerative colitis	8.08e-06	0.000972	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MAML2—ulcerative colitis	7.99e-06	0.000961	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—CXCL8—ulcerative colitis	7.92e-06	0.000952	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—PTGER4—ulcerative colitis	7.59e-06	0.000912	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL2—ulcerative colitis	7.57e-06	0.00091	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—PTGER4—ulcerative colitis	7.42e-06	0.000892	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—GHRL—ulcerative colitis	6.95e-06	0.000835	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—GHRL—ulcerative colitis	6.8e-06	0.000817	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CALM3—ulcerative colitis	6.73e-06	0.000809	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RIPK2—ulcerative colitis	6.63e-06	0.000797	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CALM3—ulcerative colitis	6.58e-06	0.000791	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RIPK2—ulcerative colitis	6.48e-06	0.000779	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADRB2—ulcerative colitis	5.75e-06	0.000691	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—JAK2—ulcerative colitis	5.67e-06	0.000682	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—JAK2—ulcerative colitis	5.55e-06	0.000667	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—CXCL8—ulcerative colitis	5.18e-06	0.000622	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—JAK2—ulcerative colitis	5.15e-06	0.000619	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—JAK2—ulcerative colitis	5.13e-06	0.000616	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—CXCL8—ulcerative colitis	5.07e-06	0.000609	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—JAK2—ulcerative colitis	5.04e-06	0.000606	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—RELA—ulcerative colitis	4.97e-06	0.000597	CbGpPWpGaD
Labetalol—ADRB1—GPCR downstream signaling—IL2—ulcerative colitis	4.95e-06	0.000595	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—ADCY5—ulcerative colitis	4.88e-06	0.000587	CbGpPWpGaD
Labetalol—ADRB2—GPCR downstream signaling—IL2—ulcerative colitis	4.84e-06	0.000582	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—ADCY5—ulcerative colitis	4.78e-06	0.000574	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—CXCL8—ulcerative colitis	4.7e-06	0.000565	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—CXCL8—ulcerative colitis	4.68e-06	0.000563	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—CXCL8—ulcerative colitis	4.6e-06	0.000553	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL2—ulcerative colitis	4.49e-06	0.00054	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL2—ulcerative colitis	4.47e-06	0.000538	CbGpPWpGaD
Labetalol—ADRB3—Signaling by GPCR—IL6—ulcerative colitis	4.45e-06	0.000535	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL2—ulcerative colitis	4.4e-06	0.000528	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS1—ulcerative colitis	4.38e-06	0.000526	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—MMP9—ulcerative colitis	4.23e-06	0.000509	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—NFKB1—ulcerative colitis	4.19e-06	0.000503	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—CALM3—ulcerative colitis	3.94e-06	0.000474	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—STAT3—ulcerative colitis	3.76e-06	0.000452	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TGFB1—ulcerative colitis	3.49e-06	0.000419	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ABCB1—ulcerative colitis	3.07e-06	0.000369	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—JAK2—ulcerative colitis	3.04e-06	0.000366	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—JAK2—ulcerative colitis	2.98e-06	0.000358	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—RELA—ulcerative colitis	2.95e-06	0.000354	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—RELA—ulcerative colitis	2.88e-06	0.000347	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—TP53—ulcerative colitis	2.87e-06	0.000345	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ADCY5—ulcerative colitis	2.86e-06	0.000344	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—CXCL8—ulcerative colitis	2.78e-06	0.000334	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—CXCL8—ulcerative colitis	2.72e-06	0.000327	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL2—ulcerative colitis	2.65e-06	0.000319	CbGpPWpGaD
Labetalol—ADRB1—Signaling by GPCR—IL6—ulcerative colitis	2.64e-06	0.000318	CbGpPWpGaD
Labetalol—ADRB3—Signaling Pathways—IL6—ulcerative colitis	2.63e-06	0.000316	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL2—ulcerative colitis	2.6e-06	0.000312	CbGpPWpGaD
Labetalol—ADRB2—Signaling by GPCR—IL6—ulcerative colitis	2.58e-06	0.000311	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—MMP9—ulcerative colitis	2.51e-06	0.000302	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—NFKB1—ulcerative colitis	2.49e-06	0.000299	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—MMP9—ulcerative colitis	2.46e-06	0.000295	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—NFKB1—ulcerative colitis	2.43e-06	0.000292	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—STAT3—ulcerative colitis	2.23e-06	0.000269	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—STAT3—ulcerative colitis	2.19e-06	0.000263	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PPARG—ulcerative colitis	2.13e-06	0.000256	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TGFB1—ulcerative colitis	2.07e-06	0.000249	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TGFB1—ulcerative colitis	2.03e-06	0.000243	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—ALB—ulcerative colitis	1.92e-06	0.000231	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—TP53—ulcerative colitis	1.7e-06	0.000205	CbGpPWpGaD
Labetalol—CYP2D6—Metabolism—PTGS2—ulcerative colitis	1.68e-06	0.000202	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—TP53—ulcerative colitis	1.67e-06	0.0002	CbGpPWpGaD
Labetalol—ADRB1—Signaling Pathways—IL6—ulcerative colitis	1.56e-06	0.000188	CbGpPWpGaD
Labetalol—ADRB2—Signaling Pathways—IL6—ulcerative colitis	1.53e-06	0.000183	CbGpPWpGaD
